Dr. Konecny is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 UCLA Medical Plz Ste 550
Los Angeles, CA 90024Phone+1 310-206-1214
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gynecologic Oncology, 2005 - 2007
- Ludwig Maximilian University of Munich Faculty of MedicineClass of 1989
Certifications & Licensure
- CA State Medical License 2013 - 2026
Clinical Trials
- Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer Start of enrollment: 2009 Jan 01
- Study of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian Cancer Start of enrollment: 2009 Jan 01
- Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer Start of enrollment: 2011 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 691 citationsActivity of the Dual Kinase Inhibitor Lapatinib (GW572016) against HER-2-Overexpressing and Trastuzumab-Treated Breast Cancer CellsGottfried E. Konecny, Mark D. Pegram, Natarajan Venkatesan, Richard S. Finn, Guorong Yang
Cancer Research. 2006-02-01 - 144 citationsNCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022.Deborah K Armstrong, Ronald D Alvarez, Floor J Backes, Jamie N Bakkum-Gamez, Lisa Barroilhet
Journal of the National Comprehensive Cancer Network. 2022-09-01 - 86 citationsUp‐regulation of L1CAM is linked to loss of hormone receptors and E‐cadherin in aggressive subtypes of endometrial carcinomasMonica Huszar, Marco Pfeifer, Uwe Schirmer, Helena Kiefel, Gottfried E. Konecny
The Journal of Pathology. 2010-04-01
Press Mentions
- Targeted Therapy for Early Breast Cancer and Advances in PSMA PET Scans at ASCOMay 22nd, 2023
- UCLA Joins Clinical Trial to Study COVID-19 in People with CancerSeptember 15th, 2020
- OncLive® Presents State of the Science Summit™ on Ovarian CancerJune 17th, 2019
- Join now to see all
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: